| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
superoxide dismutase 2 | 0.379 | 0.923 | 0.15 |
|
group | 0.510 | None | 1.000 | 0 | 0 | 2005 | 2020 | ||||||||
|
cysteine and glycine rich protein 3 | 0.572 | 0.731 | 1.6E-04 |
|
group | 0.370 | None | 1.000 | 4 | 0 | 1997 | 2019 | ||||||||
|
desmin | 0.460 | 0.846 | 8.8E-03 |
|
group | 0.400 | None | 1.000 | 2 | 0 | 1996 | 2019 | ||||||||
|
troponin T2, cardiac type | 0.601 | 0.423 | 2.0E-03 |
|
group | 0.630 | None | 1.000 | 2 | 0 | 2000 | 2019 | ||||||||
|
titin | 0.470 | 0.885 | 2.6E-96 |
|
group | 0.900 | strong | 1.000 | 1 | 0 | 1994 | 2019 | ||||||||
|
adrenoceptor beta 1 | 0.555 | 0.769 | 2.9E-06 |
|
group | 0.580 | None | 1.000 | 1 | 0 | 1998 | 2019 | ||||||||
|
prostaglandin E receptor 4 | 0.558 | 0.731 | 0.98 |
|
group | 0.210 | None | 1.000 | 0 | 0 | 2019 | 2019 | ||||||||
|
serum response factor | 0.534 | 0.808 | 0.98 |
|
group | 0.220 | None | 1.000 | 0 | 0 | 2005 | 2019 | ||||||||
|
BAG cochaperone 3 | 0.498 | 0.846 | 0.62 |
|
group | 0.400 | None | 0.955 | 0 | 0 | 2011 | 2019 | ||||||||
|
MAS related GPR family member D | 0.861 | 0.192 |
|
group | 0.210 | None | 1.000 | 0 | 0 | 2019 | 2019 | |||||||||
|
actin alpha cardiac muscle 1 | 0.610 | 0.538 | 0.74 |
|
group | 0.650 | None | 1.000 | 0 | 0 | 2006 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
group | 0.300 | None | 1.000 | 0 | 0 | 1996 | 2019 | ||||||||
|
PDZ and LIM domain 5 | 0.525 | 0.808 | 1.7E-03 |
|
group | 0.220 | None | 1.000 | 0 | 0 | 2004 | 2019 | ||||||||
|
cyclase associated actin cytoskeleton regulatory protein 2 | 0.716 | 0.423 | 0.70 |
|
group | 0.320 | None | 1.000 | 0 | 0 | 2019 | 2019 | ||||||||
|
sarcoglycan delta | 0.641 | 0.615 | 2.1E-03 |
|
group | 0.400 | None | 1.000 | 3 | 0 | 1999 | 2018 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
group | 0.230 | None | 1.000 | 1 | 0 | 1997 | 2018 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
group | 0.700 | strong | 1.000 | 1 | 0 | 1998 | 2018 | ||||||||
|
leucine rich repeat containing 10 | 0.861 | 0.115 | 0.43 |
|
group | 0.220 | None | 1.000 | 0 | 0 | 2017 | 2018 | ||||||||
|
angiotensin II receptor type 1 | 0.423 | 0.846 | 5.3E-04 |
|
group | 0.220 | None | 1.000 | 2 | 0 | 1997 | 2017 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
group | 0.210 | None | 1.000 | 1 | 0 | 2015 | 2017 | ||||||||
|
T-box transcription factor 20 | 0.663 | 0.346 | 0.97 |
|
group | 0.220 | None | 1.000 | 0 | 0 | 2016 | 2017 | ||||||||
|
mediator complex subunit 1 | 0.573 | 0.692 | 1.00 |
|
group | 0.210 | None | 1.000 | 0 | 0 | 2017 | 2017 | ||||||||
|
dynamin 1 like | 0.475 | 0.808 | 5.7E-04 |
|
group | 0.210 | None | 1.000 | 0 | 0 | 2017 | 2017 | ||||||||
|
estrogen related receptor beta | 0.565 | 0.846 | 0.13 |
|
group | 0.210 | None | 1.000 | 0 | 0 | 2017 | 2017 | ||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
group | 0.200 | None | 1.000 | 2 | 0 | 2013 | 2015 |